Varian Medical Systems, Inc, Carl Zeiss AG, and Eckert & Ziegler dominated the Global Intraoperative Radiation Therapy Market in 2020

Global Intraoperative Radiation Therapy Market is expected to grow at a CAGR of 6.7% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-intraoperative-radiation-therapy-market

Global intraoperative radiation therapy market is highly consolidated, which includes specific number of key players as well as local players. The market has witnessed increased strategic developments owing to favorable market scenario.

Major players dealing in the market are introducing a wide range of products. This helps companies maximize their sales with enhanced product portfolio.

For instance,

• In June 2021, iCAD, Inc. announced that it has signed a worldwide distribution agreement with Sectra, an international medical imaging IT and cybersecurity company. This will help the company expand its healthcare access to more facilities and imaging centers worldwide.

Varian Medical Systems, Inc is the dominating player in global market. Others are IntraOp Medical, Inc., Ariane Medical Systems Ltd, Carl Zeiss AG, Eckert & Ziegler. , Sensus Healthcare iCAD Inc., Elekta AB, SIT - S.I.T. Sordina IORT Technologies S.p.A., REMEDI Co.,Ltd., GMV,  Brainlab AG and among others.

Varian Medical Systems, Inc.

Varian Medical Systems, Inc, is headquartered in Crawley, U.K. and was founded in 1848. The company focuses on offering a wide portfolio of high-quality medical equipment and is also involved in the distribution of medical diagnostic products. It also offers a wide range of product categories including radiosurgery, radiotherapy, proton therapy, brachytherapy, adaptive therapy, interventional solutions software, and veterinary oncology, among which the market focused category is Brachytherapy.

• In April 2021, Varian Medical Systems, Inc. signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to fight the global cancer burden. This will help the company increase access to care across regional and underserviced areas in Australia and Asia.

The company has presence in Americas, Europe, Asia-Pacific, Middle East, and Africa

Eckert & Ziegler (2020)

Eckert & Ziegler (2020) is headquartered Berlin, Germany and was established in 1997. The company focuses on the provision of isotope technology for medical, scientific, and industrial use. Its core businesses are cancer therapy, industrial radiometry, and nuclear-medical imaging. The company offers a wide range of product categories including radiation therapy, radiopharma, lab devices, and engineering, among which the market focused category is radiation therapy

• In August 2020, Eckert & Ziegler and TCL Healthcare Equipment (Shanghai) Co., Ltd. signed a joint venture contract to develop, manufacture, and distribute a HDR after loader. This will help the company meet the increase demand for HDR afterloader.

The company has a presence in Americas, Europe, and Asia-Pacific

Carl Zeiss AG Carl Zeiss AG is headquartered in Baden-Württemberg, Germany and was founded in 1846. The company focuses on offering high-quality medical diagnostic tool and also provides efficiency and access to healthcare technology.. The company offers various product categories such as Data Management Software, Essential Line, Intraocular Lenses (IOLs) and OVD Portfolio, Optical Biometers, Optical Coherence Tomography (OCT) Systems, Ophthalmic Microscopes, Perimetry, Phacoemulsification, Vitrectomy and Lens Fragmentation Devices, Refractive Lasers, Retinal Cameras, Therapeutic Lasers, EyeMag Medical Loupes, Intraoperative Fluorescence Imaging, Intraoperative Radiotherapy Systems, In Vivo Pathology Suite, and Surgical Microscopes  among which Intraoperative Radiotherapy Systems  is market focused category.

• In September 2020, Carl Zeiss AG was nominated for the Deutscher Zukunftspreis 2020. This helped the company create market-shaping innovations and contribute more toward improving patients' quality of life.

The company has a presence in Americas, Europe, Middle East and Africa and Asia-Pacific